Top Markets
#1 DogBull DogBull +104.72%
#2 Siacoin Siacoin +51.67%
#3 ADO Protocol ADO Protocol +46.19%
#4 MarsCoin MarsCoin +41.08%
#5 UnifAI Network UnifAI Network +39.25%
#6 Useless Coin Useless Coin +22.93%
#7 Magma Finance Magma Finance +21.52%
#8 Ontology Gas Ontology Gas +20.36%
#9 Cash Cat Cash Cat +14.90%
#10 Apertum Apertum +14.61%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Allgens Medical Technology Co. Ltd. Allgens Medical Technology Co. Ltd.

Allgens Medical Technology Co. Ltd.

688613
Rank in Stocks #16116
Allgens Medical Technology Co. Ltd. operates as a medical device firm,... Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.
Share Price
$2.28
Market Cap
$312.51M
Change (1 day)
0.70%
Change (1 year)
-21.04%
Country
CN
Trade Allgens Medical Technology Co. Ltd. (688613)

Category

Healthcare
Revenue for Allgens Medical Technology Co. Ltd. (688613)
Revenue in Sep 2026 TTM: 0
According to Allgens Medical Technology Co. Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Allgens Medical Technology Co. Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US